 | • レポートコード：QAF27749 • 出版社/出版日：QYResearch / 2021年5月25日 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の静脈内投与溶液（コロイド）市場について種類別（末梢静脈栄養、総非経口栄養）、用途別（病院＆クリニック、歩行、ホームケア）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・静脈内投与溶液（コロイド）市場の概要 ・世界の主要地域別静脈内投与溶液（コロイド）市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の静脈内投与溶液（コロイド）市場規模2016-2021：種類別（末梢静脈栄養、総非経口栄養） ・世界の静脈内投与溶液（コロイド）市場予測2012-2027：種類別（末梢静脈栄養、総非経口栄養） ・世界の静脈内投与溶液（コロイド）市場規模2016-2021：用途別（病院＆クリニック、歩行、ホームケア） ・世界の静脈内投与溶液（コロイド）市場予測2012-2027：用途別（病院＆クリニック、歩行、ホームケア） ・静脈内投与溶液（コロイド）のアメリカ市場規模と予測2016-2021 ・静脈内投与溶液（コロイド）のヨーロッパ市場規模と予測2016-2021 ・静脈内投与溶液（コロイド）の中国市場規模と予測2016-2021 ・静脈内投与溶液（コロイド）の日本市場規模と予測2016-2021 ・静脈内投与溶液（コロイド）の東南アジア市場規模と予測2016-2021 ・静脈内投与溶液（コロイド）のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （ICU Medical Inc.、B. Braun Melsungen AG、Fresenius Kabi AG、Baxter、Amanta Healthcare、Terumo Medical Corporation、Grifols S.A.） ・静脈内投与溶液（コロイド）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・静脈内投与溶液（コロイド）の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Intravenous Solutions (Colloids) Market
The global Intravenous Solutions (Colloids) market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Intravenous Solutions (Colloids) Scope and Market Size
The global Intravenous Solutions (Colloids) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous Solutions (Colloids) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Segment by Application
Hospital & Clinics
Ambulatory
Home Care
The Intravenous Solutions (Colloids) market is analysed and market size information is provided by regions (countries). Segment by Application, the Intravenous Solutions (Colloids) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
ICU Medical Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols S.A.
1 Intravenous Solutions (Colloids) Market Overview
1.1 Intravenous Solutions (Colloids) Product Scope
1.2 Intravenous Solutions (Colloids) Segment by Type
1.2.1 Global Intravenous Solutions (Colloids) Sales by Type (2016 & 2021 & 2027)
1.2.2 Peripheral Parenteral Nutrition
1.2.3 Total Parenteral Nutrition
1.3 Intravenous Solutions (Colloids) Segment by Application
1.3.1 Global Intravenous Solutions (Colloids) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital & Clinics
1.3.3 Ambulatory
1.3.4 Home Care
1.4 Intravenous Solutions (Colloids) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Intravenous Solutions (Colloids) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Intravenous Solutions (Colloids) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Intravenous Solutions (Colloids) Price Trends (2016-2027)
2 Intravenous Solutions (Colloids) Estimates and Forecasts by Region
2.1 Global Intravenous Solutions (Colloids) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Intravenous Solutions (Colloids) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Intravenous Solutions (Colloids) Sales Market Share by Region (2016-2021)
2.2.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Region (2016-2021)
2.3 Global Intravenous Solutions (Colloids) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Intravenous Solutions (Colloids) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Intravenous Solutions (Colloids) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Intravenous Solutions (Colloids) Estimates and Projections (2016-2027)
2.4.2 Europe Intravenous Solutions (Colloids) Estimates and Projections (2016-2027)
2.4.3 China Intravenous Solutions (Colloids) Estimates and Projections (2016-2027)
2.4.4 Japan Intravenous Solutions (Colloids) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Intravenous Solutions (Colloids) Estimates and Projections (2016-2027)
2.4.6 India Intravenous Solutions (Colloids) Estimates and Projections (2016-2027)
3 Global Intravenous Solutions (Colloids) Competition Landscape by Players
3.1 Global Top Intravenous Solutions (Colloids) Players by Sales (2016-2021)
3.2 Global Top Intravenous Solutions (Colloids) Players by Revenue (2016-2021)
3.3 Global Intravenous Solutions (Colloids) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous Solutions (Colloids) as of 2020)
3.4 Global Intravenous Solutions (Colloids) Average Price by Company (2016-2021)
3.5 Manufacturers Intravenous Solutions (Colloids) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Intravenous Solutions (Colloids) Market Size by Type
4.1 Global Intravenous Solutions (Colloids) Historic Market Review by Type (2016-2021)
4.1.1 Global Intravenous Solutions (Colloids) Sales Market Share by Type (2016-2021)
4.1.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2016-2021)
4.1.3 Global Intravenous Solutions (Colloids) Price by Type (2016-2021)
4.2 Global Intravenous Solutions (Colloids) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Intravenous Solutions (Colloids) Sales Forecast by Type (2022-2027)
4.2.2 Global Intravenous Solutions (Colloids) Revenue Forecast by Type (2022-2027)
4.2.3 Global Intravenous Solutions (Colloids) Price Forecast by Type (2022-2027)
5 Global Intravenous Solutions (Colloids) Market Size by Application
5.1 Global Intravenous Solutions (Colloids) Historic Market Review by Application (2016-2021)
5.1.1 Global Intravenous Solutions (Colloids) Sales Market Share by Application (2016-2021)
5.1.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2016-2021)
5.1.3 Global Intravenous Solutions (Colloids) Price by Application (2016-2021)
5.2 Global Intravenous Solutions (Colloids) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Intravenous Solutions (Colloids) Sales Forecast by Application (2022-2027)
5.2.2 Global Intravenous Solutions (Colloids) Revenue Forecast by Application (2022-2027)
5.2.3 Global Intravenous Solutions (Colloids) Price Forecast by Application (2022-2027)
6 North America Intravenous Solutions (Colloids) Market Facts & Figures
6.1 North America Intravenous Solutions (Colloids) Sales by Company
6.1.1 North America Intravenous Solutions (Colloids) Sales by Company (2016-2021)
6.1.2 North America Intravenous Solutions (Colloids) Revenue by Company (2016-2021)
6.2 North America Intravenous Solutions (Colloids) Sales Breakdown by Type
6.2.1 North America Intravenous Solutions (Colloids) Sales Breakdown by Type (2016-2021)
6.2.2 North America Intravenous Solutions (Colloids) Sales Breakdown by Type (2022-2027)
6.3 North America Intravenous Solutions (Colloids) Sales Breakdown by Application
6.3.1 North America Intravenous Solutions (Colloids) Sales Breakdown by Application (2016-2021)
6.3.2 North America Intravenous Solutions (Colloids) Sales Breakdown by Application (2022-2027)
7 Europe Intravenous Solutions (Colloids) Market Facts & Figures
7.1 Europe Intravenous Solutions (Colloids) Sales by Company
7.1.1 Europe Intravenous Solutions (Colloids) Sales by Company (2016-2021)
7.1.2 Europe Intravenous Solutions (Colloids) Revenue by Company (2016-2021)
7.2 Europe Intravenous Solutions (Colloids) Sales Breakdown by Type
7.2.1 Europe Intravenous Solutions (Colloids) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Intravenous Solutions (Colloids) Sales Breakdown by Type (2022-2027)
7.3 Europe Intravenous Solutions (Colloids) Sales Breakdown by Application
7.3.1 Europe 137 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 137 Sales Breakdown by Application (2022-2027)
8 China Intravenous Solutions (Colloids) Market Facts & Figures
8.1 China Intravenous Solutions (Colloids) Sales by Company
8.1.1 China Intravenous Solutions (Colloids) Sales by Company (2016-2021)
8.1.2 China Intravenous Solutions (Colloids) Revenue by Company (2016-2021)
8.2 China Intravenous Solutions (Colloids) Sales Breakdown by Type
8.2.1 China Intravenous Solutions (Colloids) Sales Breakdown by Type (2016-2021)
8.2.2 China Intravenous Solutions (Colloids) Sales Breakdown by Type (2022-2027)
8.3 China Intravenous Solutions (Colloids) Sales Breakdown by Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)
9 Japan Intravenous Solutions (Colloids) Market Facts & Figures
9.1 Japan Intravenous Solutions (Colloids) Sales by Company
9.1.1 Japan Intravenous Solutions (Colloids) Sales by Company (2016-2021)
9.1.2 Japan Intravenous Solutions (Colloids) Revenue by Company (2016-2021)
9.2 Japan Intravenous Solutions (Colloids) Sales Breakdown by Type
9.2.1 Japan Intravenous Solutions (Colloids) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Intravenous Solutions (Colloids) Sales Breakdown by Type (2022-2027)
9.3 Japan Intravenous Solutions (Colloids) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Intravenous Solutions (Colloids) Market Facts & Figures
10.1 Southeast Asia Intravenous Solutions (Colloids) Sales by Company
10.1.1 Southeast Asia Intravenous Solutions (Colloids) Sales by Company (2016-2021)
10.1.2 Southeast Asia Intravenous Solutions (Colloids) Revenue by Company (2016-2021)
10.2 Southeast Asia Intravenous Solutions (Colloids) Sales Breakdown by Type
10.2.1 Southeast Asia Intravenous Solutions (Colloids) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Intravenous Solutions (Colloids) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Intravenous Solutions (Colloids) Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Intravenous Solutions (Colloids) Market Facts & Figures
11.1 India Intravenous Solutions (Colloids) Sales by Company
11.1.1 India Intravenous Solutions (Colloids) Sales by Company (2016-2021)
11.1.2 India Intravenous Solutions (Colloids) Revenue by Company (2016-2021)
11.2 India Intravenous Solutions (Colloids) Sales Breakdown by Type
11.2.1 India Intravenous Solutions (Colloids) Sales Breakdown by Type (2016-2021)
11.2.2 India Intravenous Solutions (Colloids) Sales Breakdown by Type (2022-2027)
11.3 India Intravenous Solutions (Colloids) Sales Breakdown by Application
11.3.1 India Intravenous Solutions (Colloids) Sales Breakdown by Application (2016-2021)
11.3.2 India Intravenous Solutions (Colloids) Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Intravenous Solutions (Colloids) Business
12.1 ICU Medical Inc.
12.1.1 ICU Medical Inc. Corporation Information
12.1.2 ICU Medical Inc. Business Overview
12.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 ICU Medical Inc. Intravenous Solutions (Colloids) Products Offered
12.1.5 ICU Medical Inc. Recent Development
12.2 B. Braun Melsungen AG
12.2.1 B. Braun Melsungen AG Corporation Information
12.2.2 B. Braun Melsungen AG Business Overview
12.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 B. Braun Melsungen AG Intravenous Solutions (Colloids) Products Offered
12.2.5 B. Braun Melsungen AG Recent Development
12.3 Fresenius Kabi AG
12.3.1 Fresenius Kabi AG Corporation Information
12.3.2 Fresenius Kabi AG Business Overview
12.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Fresenius Kabi AG Intravenous Solutions (Colloids) Products Offered
12.3.5 Fresenius Kabi AG Recent Development
12.4 Baxter
12.4.1 Baxter Corporation Information
12.4.2 Baxter Business Overview
12.4.3 Baxter Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Baxter Intravenous Solutions (Colloids) Products Offered
12.4.5 Baxter Recent Development
12.5 Amanta Healthcare
12.5.1 Amanta Healthcare Corporation Information
12.5.2 Amanta Healthcare Business Overview
12.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Amanta Healthcare Intravenous Solutions (Colloids) Products Offered
12.5.5 Amanta Healthcare Recent Development
12.6 Terumo Medical Corporation
12.6.1 Terumo Medical Corporation Corporation Information
12.6.2 Terumo Medical Corporation Business Overview
12.6.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Terumo Medical Corporation Intravenous Solutions (Colloids) Products Offered
12.6.5 Terumo Medical Corporation Recent Development
12.7 Grifols S.A.
12.7.1 Grifols S.A. Corporation Information
12.7.2 Grifols S.A. Business Overview
12.7.3 Grifols S.A. Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Grifols S.A. Intravenous Solutions (Colloids) Products Offered
12.7.5 Grifols S.A. Recent Development
…
13 Intravenous Solutions (Colloids) Manufacturing Cost Analysis
13.1 Intravenous Solutions (Colloids) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Intravenous Solutions (Colloids)
13.4 Intravenous Solutions (Colloids) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Intravenous Solutions (Colloids) Distributors List
14.3 Intravenous Solutions (Colloids) Customers
15 Market Dynamics
15.1 Intravenous Solutions (Colloids) Market Trends
15.2 Intravenous Solutions (Colloids) Drivers
15.3 Intravenous Solutions (Colloids) Market Challenges
15.4 Intravenous Solutions (Colloids) Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Intravenous Solutions (Colloids) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Intravenous Solutions (Colloids) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Intravenous Solutions (Colloids) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Intravenous Solutions (Colloids) Sales (K Units) by Region (2016-2021)
Table 5. Global Intravenous Solutions (Colloids) Sales Market Share by Region (2016-2021)
Table 6. Global Intravenous Solutions (Colloids) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Intravenous Solutions (Colloids) Revenue Share by Region (2016-2021)
Table 8. Global Intravenous Solutions (Colloids) Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Intravenous Solutions (Colloids) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Intravenous Solutions (Colloids) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Intravenous Solutions (Colloids) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Intravenous Solutions (Colloids) Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Intravenous Solutions (Colloids) Sales Share by Company (2016-2021)
Table 14. Global Intravenous Solutions (Colloids) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Intravenous Solutions (Colloids) Revenue Share by Company (2016-2021)
Table 16. Global Intravenous Solutions (Colloids) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Solutions (Colloids) as of 2020)
Table 17. Global Intravenous Solutions (Colloids) Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Intravenous Solutions (Colloids) Manufacturing Sites and Area Served
Table 19. Manufacturers Intravenous Solutions (Colloids) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Intravenous Solutions (Colloids) Sales (K Units) by Type (2016-2021)
Table 22. Global Intravenous Solutions (Colloids) Sales Share by Type (2016-2021)
Table 23. Global Intravenous Solutions (Colloids) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Type (2016-2021)
Table 25. Global Intravenous Solutions (Colloids) Sales Share by Type (2022-2027)
Table 26. Global Intravenous Solutions (Colloids) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Intravenous Solutions (Colloids) Revenue Share by Type (2022-2027)
Table 28. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Type (2022-2027)
Table 29. Global Intravenous Solutions (Colloids) Sales (K Units) by Application (2016-2021)
Table 30. Global Intravenous Solutions (Colloids) Sales Share by Application (2016-2021)
Table 31. Global Intravenous Solutions (Colloids) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Application (2016-2021)
Table 33. Global Intravenous Solutions (Colloids) Sales (K Units) by Application (2022-2027)
Table 34. Global Intravenous Solutions (Colloids) Sales Share by Application (2022-2027)
Table 35. Global Intravenous Solutions (Colloids) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Intravenous Solutions (Colloids) Revenue Share by Application (2022-2027)
Table 37. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Application (2022-2027)
Table 38. North America Intravenous Solutions (Colloids) Sales (K Units) by Company (2016-2021)
Table 39. North America Intravenous Solutions (Colloids) Sales Market Share by Company (2016-2021)
Table 40. North America Intravenous Solutions (Colloids) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Intravenous Solutions (Colloids) Revenue Market Share by Company (2016-2021)
Table 42. North America Intravenous Solutions (Colloids) Sales by Type (2016-2021) & (K Units)
Table 43. North America Intravenous Solutions (Colloids) Sales Market Share by Type (2016-2021)
Table 44. North America Intravenous Solutions (Colloids) Sales by Type (2022-2027) & (K Units)
Table 45. North America Intravenous Solutions (Colloids) Sales Market Share by Type (2022-2027)
Table 46. North America Intravenous Solutions (Colloids) Sales by Application (2016-2021) & (K Units)
Table 47. North America Intravenous Solutions (Colloids) Sales Market Share by Application (2016-2021)
Table 48. North America Intravenous Solutions (Colloids) Sales by Application (2022-2027) & (K Units)
Table 49. North America Intravenous Solutions (Colloids) Sales Market Share by Application (2022-2027)
Table 50. Europe Intravenous Solutions (Colloids) Sales (K Units) by Company (2016-2021)
Table 51. Europe Intravenous Solutions (Colloids) Sales Market Share by Company (2016-2021)
Table 52. Europe Intravenous Solutions (Colloids) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Intravenous Solutions (Colloids) Revenue Market Share by Company (2016-2021)
Table 54. Europe Intravenous Solutions (Colloids) Sales by Type (2016-2021) & (K Units)
Table 55. Europe Intravenous Solutions (Colloids) Sales Market Share by Type (2016-2021)
Table 56. Europe Intravenous Solutions (Colloids) Sales by Type (2022-2027) & (K Units)
Table 57. Europe Intravenous Solutions (Colloids) Sales Market Share by Type (2022-2027)
Table 58. Europe Intravenous Solutions (Colloids) Sales by Application (2016-2021) & (K Units)
Table 59. Europe Intravenous Solutions (Colloids) Sales Market Share by Application (2016-2021)
Table 60. Europe Intravenous Solutions (Colloids) Sales by Application (2022-2027) & (K Units)
Table 61. Europe Intravenous Solutions (Colloids) Sales Market Share by Application (2022-2027)
Table 62. China Intravenous Solutions (Colloids) Sales (K Units) by Company (2016-2021)
Table 63. China Intravenous Solutions (Colloids) Sales Market Share by Company (2016-2021)
Table 64. China Intravenous Solutions (Colloids) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Intravenous Solutions (Colloids) Revenue Market Share by Company (2016-2021)
Table 66. China Intravenous Solutions (Colloids) Sales by Type (2016-2021) & (K Units)
Table 67. China Intravenous Solutions (Colloids) Sales Market Share by Type (2016-2021)
Table 68. China Intravenous Solutions (Colloids) Sales by Type (2022-2027) & (K Units)
Table 69. China Intravenous Solutions (Colloids) Sales Market Share by Type (2022-2027)
Table 70. China Intravenous Solutions (Colloids) Sales by Application (2016-2021) & (K Units)
Table 71. China Intravenous Solutions (Colloids) Sales Market Share by Application (2016-2021)
Table 72. China Intravenous Solutions (Colloids) Sales by Application (2022-2027) & (K Units)
Table 73. China Intravenous Solutions (Colloids) Sales Market Share by Application (2022-2027)
Table 74. Japan Intravenous Solutions (Colloids) Sales (K Units) by Company (2016-2021)
Table 75. Japan Intravenous Solutions (Colloids) Sales Market Share by Company (2016-2021)
Table 76. Japan Intravenous Solutions (Colloids) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Intravenous Solutions (Colloids) Revenue Market Share by Company (2016-2021)
Table 78. Japan Intravenous Solutions (Colloids) Sales by Type (2016-2021) & (K Units)
Table 79. Japan Intravenous Solutions (Colloids) Sales Market Share by Type (2016-2021)
Table 80. Japan Intravenous Solutions (Colloids) Sales by Type (2022-2027) & (K Units)
Table 81. Japan Intravenous Solutions (Colloids) Sales Market Share by Type (2022-2027)
Table 82. Japan Intravenous Solutions (Colloids) Sales by Application (2016-2021) & (K Units)
Table 83. Japan Intravenous Solutions (Colloids) Sales Market Share by Application (2016-2021)
Table 84. Japan Intravenous Solutions (Colloids) Sales by Application (2022-2027) & (K Units)
Table 85. Japan Intravenous Solutions (Colloids) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Intravenous Solutions (Colloids) Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Intravenous Solutions (Colloids) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Intravenous Solutions (Colloids) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Intravenous Solutions (Colloids) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Intravenous Solutions (Colloids) Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Intravenous Solutions (Colloids) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Intravenous Solutions (Colloids) Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Intravenous Solutions (Colloids) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Intravenous Solutions (Colloids) Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Intravenous Solutions (Colloids) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Intravenous Solutions (Colloids) Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Intravenous Solutions (Colloids) Sales Market Share by Application (2022-2027)
Table 98. India Intravenous Solutions (Colloids) Sales (K Units) by Company (2016-2021)
Table 99. India Intravenous Solutions (Colloids) Sales Market Share by Company (2016-2021)
Table 100. India Intravenous Solutions (Colloids) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Intravenous Solutions (Colloids) Revenue Market Share by Company (2016-2021)
Table 102. India Intravenous Solutions (Colloids) Sales by Type (2016-2021) & (K Units)
Table 103. India Intravenous Solutions (Colloids) Sales Market Share by Type (2016-2021)
Table 104. India Intravenous Solutions (Colloids) Sales by Type (2022-2027) & (K Units)
Table 105. India Intravenous Solutions (Colloids) Sales Market Share by Type (2022-2027)
Table 106. India Intravenous Solutions (Colloids) Sales by Application (2016-2021) & (K Units)
Table 107. India Intravenous Solutions (Colloids) Sales Market Share by Application (2016-2021)
Table 108. India Intravenous Solutions (Colloids) Sales by Application (2022-2027) & (K Units)
Table 109. India Intravenous Solutions (Colloids) Sales Market Share by Application (2022-2027)
Table 110. ICU Medical Inc. Corporation Information
Table 111. ICU Medical Inc. Description and Business Overview
Table 112. ICU Medical Inc. Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. ICU Medical Inc. Intravenous Solutions (Colloids) Product
Table 114. ICU Medical Inc. Recent Development
Table 115. B. Braun Melsungen AG Corporation Information
Table 116. B. Braun Melsungen AG Description and Business Overview
Table 117. B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. B. Braun Melsungen AG Intravenous Solutions (Colloids) Product
Table 119. B. Braun Melsungen AG Recent Development
Table 120. Fresenius Kabi AG Corporation Information
Table 121. Fresenius Kabi AG Description and Business Overview
Table 122. Fresenius Kabi AG Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Fresenius Kabi AG Intravenous Solutions (Colloids) Product
Table 124. Fresenius Kabi AG Recent Development
Table 125. Baxter Corporation Information
Table 126. Baxter Description and Business Overview
Table 127. Baxter Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Baxter Intravenous Solutions (Colloids) Product
Table 129. Baxter Recent Development
Table 130. Amanta Healthcare Corporation Information
Table 131. Amanta Healthcare Description and Business Overview
Table 132. Amanta Healthcare Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Amanta Healthcare Intravenous Solutions (Colloids) Product
Table 134. Amanta Healthcare Recent Development
Table 135. Terumo Medical Corporation Corporation Information
Table 136. Terumo Medical Corporation Description and Business Overview
Table 137. Terumo Medical Corporation Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Terumo Medical Corporation Intravenous Solutions (Colloids) Product
Table 139. Terumo Medical Corporation Recent Development
Table 140. Grifols S.A. Corporation Information
Table 141. Grifols S.A. Description and Business Overview
Table 142. Grifols S.A. Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Grifols S.A. Intravenous Solutions (Colloids) Product
Table 144. Grifols S.A. Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Intravenous Solutions (Colloids) Distributors List
Table 148. Intravenous Solutions (Colloids) Customers List
Table 149. Intravenous Solutions (Colloids) Market Trends
Table 150. Intravenous Solutions (Colloids) Market Drivers
Table 151. Intravenous Solutions (Colloids) Market Challenges
Table 152. Intravenous Solutions (Colloids) Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous Solutions (Colloids) Product Picture
Figure 2. Global Intravenous Solutions (Colloids) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Intravenous Solutions (Colloids) Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital & Clinics Examples
Figure 7. Ambulatory Examples
Figure 8. Home Care Examples
Figure 9. Global Intravenous Solutions (Colloids) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Intravenous Solutions (Colloids) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Intravenous Solutions (Colloids) Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Intravenous Solutions (Colloids) Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Intravenous Solutions (Colloids) Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Intravenous Solutions (Colloids) Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Intravenous Solutions (Colloids) Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Intravenous Solutions (Colloids) Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Intravenous Solutions (Colloids) Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Intravenous Solutions (Colloids) Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Intravenous Solutions (Colloids) Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Intravenous Solutions (Colloids) Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Intravenous Solutions (Colloids) Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Intravenous Solutions (Colloids) Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Intravenous Solutions (Colloids) Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Intravenous Solutions (Colloids) Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Intravenous Solutions (Colloids) Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Intravenous Solutions (Colloids) Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Intravenous Solutions (Colloids) Players Market Share by Revenue in Intravenous Solutions (Colloids): 2016 & 2020
Figure 28. Intravenous Solutions (Colloids) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Intravenous Solutions (Colloids) Revenue Share by Type (2016-2021)
Figure 30. Global Intravenous Solutions (Colloids) Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Intravenous Solutions (Colloids) Revenue Share by Application (2016-2021)
Figure 32. Global Intravenous Solutions (Colloids) Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Intravenous Solutions (Colloids) Sales Market Share by Type in 2020
Figure 34. North America Intravenous Solutions (Colloids) Sales Market Share by Application in 2020
Figure 35. Europe Intravenous Solutions (Colloids) Sales Market Share by Type in 2020
Figure 36. Europe Intravenous Solutions (Colloids) Sales Market Share by Application in 2020
Figure 37. China Intravenous Solutions (Colloids) Sales Market Share by Type in 2020
Figure 38. China Intravenous Solutions (Colloids) Sales Market Share by Application in 2020
Figure 39. Japan Intravenous Solutions (Colloids) Sales Market Share by Type in 2020
Figure 40. Japan Intravenous Solutions (Colloids) Sales Market Share by Application in 2020
Figure 41. Southeast Asia Intravenous Solutions (Colloids) Sales Market Share by Type in 2020
Figure 42. Southeast Asia Intravenous Solutions (Colloids) Sales Market Share by Application in 2020
Figure 43. India Intravenous Solutions (Colloids) Sales Market Share by Type in 2020
Figure 44. India Intravenous Solutions (Colloids) Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Intravenous Solutions (Colloids)
Figure 47. Manufacturing Process Analysis of Intravenous Solutions (Colloids)
Figure 48. Intravenous Solutions (Colloids) Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed